A. JANS PHARMA

Bree ·KBO/BCE: BE 0754.509.847

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	27-08-2025	27 d late	2025-00410405
31-12-2023	31-07-2024	25-07-2024	6 d early	2024-00281213
31-12-2022	31-07-2023	30-08-2023	30 d late	2023-00377528
31-12-2021	31-07-2022	31-08-2022	31 d late	2022-20369245

Metric	This company	Sector median	Position in the sector
Solvency	42.0%	52.5%	better than 42% of 3139 sector peers
Net result	€67k	€32k	better than 72% of 3135 sector peers
Equity	€539k	€75k	better than 92% of 3140 sector peers
Gross operating margin	€123k	€52k	better than 79% of 3132 sector peers
Staff costs	€2k	€9k	higher than 36% of 277 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.28M
Fixed assets	21/28	€1.27M
Formation expenses	20	€0
Financial fixed assets	28	€1.27M
Current assets	29/58	€10k
Amounts receivable within one year	40/41	€3k
Cash & bank	54/58	€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.28M
Equity	10/15	€539k
Contributions / capital	10/11	€176k
Reserves	13	€361k
Accumulated profits (losses)	14	€2k
Amounts payable	17/49	€744k
Amounts payable after one year	17	€507k
Amounts payable within one year	42/48	€237k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€123k
Operating result	9901	€120k
Financial charges	65	€32k
Result before taxes	9903	€89k
Income taxes	67/77	€22k
Net result for the period	9904	€67k
Result to be appropriated	9905	€67k

Summary